AIMC Topic: Non-alcoholic Fatty Liver Disease

Clear Filters Showing 61 to 70 of 123 articles

Danshao Shugan Granule therapy for non-alcoholic fatty liver disease.

Lipids in health and disease Aug 23, 2022
BACKGROUND: Danshao Shugan Granules (DSSG), a traditional Chinese medicine (TCM), is given to protect the liver. The objective is to evaluate the mechanisms of the effects of DSSG on non-alcoholic fatty liver disease (NAFLD).
Rosiglitazone Mice Silybin Rats Malondialdehyde Alanine Transaminase Rats, Sprague-Dawley Aspartate Aminotransferases Liver Triglycerides Superoxide Dismutase Humans Medicine, Chinese Traditional Animals NF-kappa B Cholesterol Non-alcoholic Fatty Liver Disease
View on PubMed DOI

Comparative Study of Raw Ultrasound Data Representations in Deep Learning to Classify Hepatic Steatosis.

Ultrasound in medicine & biology Jul 30, 2022
Adiposity accumulation in the liver is an early-stage indicator of non-alcoholic fatty liver disease. Analysis of ultrasound (US) backscatter echoes from liver parenchyma with deep learning (DL) may offer an affordable alternative for hepatic steatos...
Humans Liver Ultrasonography Artificial Intelligence Non-alcoholic Fatty Liver Disease ROC Curve Deep Learning
View on PubMed DOI

Very low-volume interval training improves nonalcoholic fatty liver disease fibrosis score and cardiometabolic health in adults with obesity and metabolic syndrome.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society Apr 24, 2022
Non-alcoholic fatty liver disease (NAFLD) and cardiometabolic disorders are highly prevalent in obese individuals. Physical exercise is an important element in obesity and metabolic syndrome (MetS) treatment. However, the vast majority of individuals...
Weight Loss Non-alcoholic Fatty Liver Disease Humans Metabolic Syndrome Adult Fibrosis Obesity Cardiovascular Diseases
View on PubMed DOI

The Anti-Adiposity Mechanisms of Ampelopsin and Vine Tea Extract in High Fat Diet and Alcohol-Induced Fatty Liver Mouse Models.

Molecules (Basel, Switzerland) Jan 18, 2022
(AG) is an ancient medicinal plant that is mainly distributed and used in southwest China. It exerts therapeutic effects, such as antioxidant, anti-diabetic, and anti-inflammatory activities, reductions in blood pressure and cholesterol and hepatopr...
Mice, Obese Phytotherapy Lipogenesis Fatty Liver, Alcoholic Obesity Diet, High-Fat Anti-Obesity Agents Rats Rats, Sprague-Dawley Mice, Inbred C57BL Animals Lipid Metabolism Adiposity Tea Antioxidants Non-alcoholic Fatty Liver Disease Male 3T3-L1 Cells Flavonoids Plant Extracts Mice Mice, Inbred ICR
View on PubMed DOI

Automated Whole-Liver MRI Segmentation to Assess Steatosis and Iron Quantification in Chronic Liver Disease.

Radiology Nov 16, 2021
Background Standardized manual region of interest (ROI) sampling strategies for hepatic MRI steatosis and iron quantification are time consuming, with variable results. Purpose To evaluate the performance of automatic MRI whole-liver segmentation (WL...
Biopsy Non-alcoholic Fatty Liver Disease Iron Overload Deep Learning Humans Magnetic Resonance Imaging Prospective Studies Chronic Disease Male Middle Aged Female Cross-Sectional Studies
View on PubMed DOI

Development of machine learning model to detect fibrotic non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver Aug 13, 2021
Humans Machine Learning Male Middle Aged Non-alcoholic Fatty Liver Disease Fibrosis Female Adult Cross-Sectional Studies
View on PubMed DOI

Application of Artificial Intelligence for Diagnosis and Risk Stratification in NAFLD and NASH: The State of the Art.

Hepatology (Baltimore, Md.) Aug 10, 2021
The diagnosis of nonalcoholic fatty liver disease and associated fibrosis is challenging given the lack of signs, symptoms and nonexistent diagnostic test. Furthermore, follow up and treatment decisions become complicated with a lack of a simple repr...
Diagnostic Techniques, Digestive System Risk Assessment Liver Cirrhosis Humans Non-alcoholic Fatty Liver Disease Neural Networks, Computer Artificial Intelligence
View on PubMed DOI

A Machine Learning Approach Enables Quantitative Measurement of Liver Histology and Disease Monitoring in NASH.

Hepatology (Baltimore, Md.) Jun 24, 2021
BACKGROUND AND AIMS: Manual histological assessment is currently the accepted standard for diagnosing and monitoring disease progression in NASH, but is limited by variability in interpretation and insensitivity to change. Thus, there is a critical n...
Non-alcoholic Fatty Liver Disease Liver Randomized Controlled Trials as Topic Biopsy Humans Reproducibility of Results Image Processing, Computer-Assisted Liver Cirrhosis Severity of Illness Index Deep Learning
View on PubMed DOI

Artificial Intelligence in NASH Histology: Human Teaches a Machine for the Machine to Help Humans.

Hepatology (Baltimore, Md.) May 22, 2021
Non-alcoholic Fatty Liver Disease Humans Artificial Intelligence Machine Learning
View on PubMed DOI

Coupling Machine Learning and Lipidomics as a Tool to Investigate Metabolic Dysfunction-Associated Fatty Liver Disease. A General Overview.

Biomolecules Mar 22, 2021
Hepatic biopsy is the gold standard for staging nonalcoholic fatty liver disease (NAFLD). Unfortunately, accessing the liver is invasive, requires a multidisciplinary team and is too expensive to be conducted on large segments of the population. NAFL...
Non-alcoholic Fatty Liver Disease Bariatric Surgery Lipidomics Humans Animals Artificial Intelligence Adipose Tissue Machine Learning
View on PubMed DOI
Popular Topics
Recent Journals